<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00787904</url>
  </required_header>
  <id_info>
    <org_study_id>T-cells in osteoporosis</org_study_id>
    <nct_id>NCT00787904</nct_id>
  </id_info>
  <brief_title>Role of T-cells in Post-Menopausal Osteoporosis</brief_title>
  <official_title>The Role of T-cells in Women Undergoing Surgical Menopause</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atlanta VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Atlanta VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study of women undergoing surgical menopause to determine whether
      T-cells play an important role in the etiology of post-menopausal osteoporosis. Subjects will
      examined before and after surgery and followed over a two year period to determine the
      biology of T-cells during this study period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Estrogen (E) deficiency is a major cause of post-menopausal osteoporosis. The mechanisms by
      which E deficiency causes osteoporosis has been recently linked to regulation of two key
      osteoclastic cytokines: RANKL and TNFÎ± (TNF) , , produced by the T-cell in the bone
      micro-environment. TNF is a cytokine that has long been associated with bone destruction
      during E deficiency in both animal and human models. However, the cellular sources of TNF and
      its exact mechanism of action are poorly understood. Previous studies in animal models has
      demonstrated that in marked contrast to responses in wild type (WT) mice, ovariectomy (ovx)
      failed to induce bone loss and did not stimulate osteoclast (OC) formation in T-cell
      deficient mice. This phenomenon is reversed by T cell reconstitution with WT T cells but not
      with T cells from TNF -/- mice2,4. These findings established T-cells and T-cell produced TNF
      as essential mediators of the bone-wasting effects of E deficiency in vivo. TNF further
      enhances OC formation by up regulating the stromal cell production of RANKL and M-CSF and by
      augmenting the responsiveness of OC precursors to RANKL4. The mechanisms by which E
      deficiency leads to enhanced levels of T-cell derived TNF involve a realignment of the
      adaptive immune response that ultimately leads to an expansion in the pool of TNF secreting
      T-cells. Dr. Pacifici's group showed that these pathways in mouse models involve the
      up-regulation of antigen presentation by macrophages and dendritic cells, leading to T cell
      activation and peripheral expansion of TNF producing T cells. They also showed that E
      deficiency causes a rebound in thymic T cell output that contributes to both the T cell
      expansion and the bone loss induced by ovx in young adult mice .

      The objective of this study is to translate these critical findings in the mouse for the
      first time to E deficient women following ovx. If this work defines an important role for
      T-cells in E deficiency-induced bone loss, this could stimulate the development of novel
      therapies designed to block T-cell expansion or their contribution to cytokine production and
      thus prevent or attenuate bone loss in this common clinical setting. The hypothesis of the
      research plan is that T-cells derived from women, rendered E deficient after undergoing ovx,
      exhibit: 1) increased T-cell activation, and proliferation; 2) enhanced production of
      pro-osteoclastogenic cytokines RANKL and TNF; and 3) demonstrate increased T-cell output from
      the thymus that together cause bone loss.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in T-cell Activation Measured by Flow Cytometry, Specifically the Percentage of CD3+CD69+ T-cells</measure>
    <time_frame>2 years</time_frame>
    <description>(Please note to reviewer, CD3 positivity indicates a T-cell, the title is correct)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent Change in Thymus Size Measured by CT Scan</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone Mineral Density</measure>
    <time_frame>2 years</time_frame>
    <description>Please note that the bone density measurements were done AFTER THE PRIMARY endpoints because bone mineral density changes take longer to see differences</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">19</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Surgical Menopause</arm_group_label>
    <description>Pre-menopausal women undergoing total hysterectomy with oophorectomy rendering them post-menopausal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical Control</arm_group_label>
    <description>Pre-menopausal women undergoing abdominal surgery but without ovary removal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Healthy matched pre-menopausal controls</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pre-menopausal Women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women between the age of 18-55, pre-menopausal by history (regular spontaneous
             menstrual bleeding every 21-35 days) or documented FSH &lt;10, no current estrogen
             therapy, undergoing hysterectomy with (ovx) or without ovariectomy (control group) for
             benign gynecologic disease (fibroid uterus, endometriosis, dysfunctional uterine
             bleeding, chronic pelvic pain) or for prophylaxis against ovarian cancer (BRCA
             positive).

        Exclusion Criteria:

          -  History of an active cancer including breast and uterine cancer, treatment with
             chemotherapy or glucocorticoids

          -  History of an immune deficiency syndrome including HIV infection

          -  History of severe anemia with hematocrit &lt; 25.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vin Tangpricha, M.D./Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University/Atlanta VAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2008</study_first_submitted>
  <study_first_submitted_qc>November 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2008</study_first_posted>
  <results_first_submitted>June 22, 2015</results_first_submitted>
  <results_first_submitted_qc>October 21, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 13, 2016</results_first_posted>
  <last_update_submitted>October 21, 2016</last_update_submitted>
  <last_update_submitted_qc>October 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atlanta VA Medical Center</investigator_affiliation>
    <investigator_full_name>Vin Tangpricha</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Osteoporosis, T-cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Osteoporosis, Postmenopausal</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Surgical Menopause</title>
          <description>Pre-menopausal women undergoing total hysterectomy with oophorectomy rendering them post-menopausal</description>
        </group>
        <group group_id="P2">
          <title>Surgical Control</title>
          <description>Pre-menopausal women with or without surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Surgical Menopause</title>
          <description>Pre-menopausal women undergoing total hysterectomy with oophorectomy rendering them post-menopausal</description>
        </group>
        <group group_id="B2">
          <title>Surgical Control</title>
          <description>Pre-menopausal women undergoing abdominal surgery but without ovary removal</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.3" spread="5.1"/>
                    <measurement group_id="B2" value="41.4" spread="7.1"/>
                    <measurement group_id="B3" value="42.9" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in T-cell Activation Measured by Flow Cytometry, Specifically the Percentage of CD3+CD69+ T-cells</title>
        <description>(Please note to reviewer, CD3 positivity indicates a T-cell, the title is correct)</description>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Surgical Menopause</title>
            <description>Pre-menopausal women undergoing total hysterectomy with oophorectomy rendering them post-menopausal</description>
          </group>
          <group group_id="O2">
            <title>Surgical Control</title>
            <description>Pre-menopausal women undergoing abdominal surgery but without ovary removal</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in T-cell Activation Measured by Flow Cytometry, Specifically the Percentage of CD3+CD69+ T-cells</title>
          <description>(Please note to reviewer, CD3 positivity indicates a T-cell, the title is correct)</description>
          <units>percentage of CD3 positive cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="0.5"/>
                    <measurement group_id="O2" value="1.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent Change in Thymus Size Measured by CT Scan</title>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Surgical Menopause</title>
            <description>Pre-menopausal women undergoing total hysterectomy with oophorectomy rendering them post-menopausal</description>
          </group>
          <group group_id="O2">
            <title>Surgical Control</title>
            <description>Pre-menopausal women undergoing abdominal surgery but without ovary removal</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Thymus Size Measured by CT Scan</title>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7" spread="2"/>
                    <measurement group_id="O2" value="17" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bone Mineral Density</title>
        <description>Please note that the bone density measurements were done AFTER THE PRIMARY endpoints because bone mineral density changes take longer to see differences</description>
        <time_frame>2 years</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Surgical Menopause</title>
          <description>Pre-menopausal women undergoing total hysterectomy with oophorectomy rendering them post-menopausal</description>
        </group>
        <group group_id="E2">
          <title>Surgical Control</title>
          <description>Pre-menopausal women undergoing abdominal surgery but without ovary removal</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Vin Tangpricha</name_or_title>
      <organization>Emory University</organization>
      <phone>404-727-7254</phone>
      <email>vin.tangpricha@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

